Russell Fedewa

Title: Russell Fedewa: Innovator in Cardiac Assessment Technology

Introduction

Russell Fedewa is a notable inventor based in Shaker Heights, OH (US). He has made significant contributions to the field of cardiac health through his innovative patent. His work focuses on improving the assessment of myocardial viability, which is crucial for patients undergoing treatment for atrial fibrillation.

Latest Patents

Russell Fedewa holds a patent titled "Assessment of atrial myocardial viability using spectral analysis of ultrasound." This patent describes a method where spectral parameters of ultrasound backscatter from myocardial tissue can be utilized to identify fibrosis and accurately assess myocardial viability during ablation procedures. The process involves ultrasonically insonifying a portion of myocardial tissue, measuring the backscatter signal of ultrasonic waves, and determining a spectral parameter of that signal. This spectral parameter is then correlated with the electrical conductivity of the myocardial tissue, allowing for adjustments in patient treatment based on the correlation.

Career Highlights

Russell is associated with the Cleveland Clinic Foundation, a prestigious institution known for its commitment to medical innovation and patient care. His work there has been instrumental in advancing techniques that enhance the understanding and treatment of cardiac conditions.

Collaborations

Russell has collaborated with esteemed colleagues such as Oussama Wazni and Scott Anjewierden. Their combined expertise contributes to the development of cutting-edge solutions in cardiac health.

Conclusion

Russell Fedewa's innovative work in the assessment of myocardial viability showcases the potential of ultrasound technology in improving patient outcomes in cardiac care. His contributions are paving the way for advancements in the treatment of atrial fibrillation and enhancing the overall understanding of heart health.